Capecitabine: An Oral Fluoropyrimidine In Cancer Therapy: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

17 June 2026

  • curprev 16:1316:13, 17 June 2026‎ SangWatriama talk contribs‎ 7,625 bytes +7,625‎ Created page with "<br>Capecitabine is an oral prodrug of the antimetabolite 5-fluorouracil (5-FU) that is widely used in the treatment of several solid tumors, particularly colorectal and breast cancers. Developed to improve the therapeutic index and convenience of intravenous 5-FU, capecitabine undergoes a multistep enzymatic activation process preferentially in tumor tissues, thereby increasing local drug concentration while reducing systemic toxicity. This report provides a concise ove..."
Retrieved from "https://wiki.seti-hub.org/w/index.php?title=Capecitabine:_An_Oral_Fluoropyrimidine_In_Cancer_Therapy"